Thiamine Hydrochloride Injection, Solution
Product Images NDC 72603-565

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Thiamine Hydrochloride (NDC 72603-565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Thiaminestructure (Thiaminestructure)

Chemical structure of thiamine hydrochloride, showing the molecular framework including pyrimidine and thiazolium rings, and the hydrochloride salt component.*

FDA Label Image

Thiaminecontainerlabel (Thiaminecontainerlabel)

Label for Thiamine Hydrochloride Injection, USP, 200 mg per 2 mL (100 mg/mL) multiple-dose vial. Intended for intramuscular or intravenous use, manufactured by Aspiro Pharma Limited for Northstar Rx LLC. Includes NDC 72603-565-01, lot and expiration placeholders, and a barcode.*

FDA Label Image

Thiaminecartonlabel (Thiaminecartonlabel)

Packaging label for Thiamine Hydrochloride Injection USP, 200 mg per 2 mL solution (100 mg per mL) by NorthStar RxLLC. This prescription drug is intended for intramuscular or intravenous use and comes in a carton containing 25 x 2 mL multiple-dose vials. The label notes storage instructions and manufacturing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.